| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000084541 |
| P698 | PubMed publication ID | 15905616 |
| P2093 | author name string | Zhang Y | |
| Li Q | |||
| Chen XH | |||
| Yu YY | |||
| Ji YB | |||
| Lin YZ | |||
| Liu BY | |||
| Zhu ZG | |||
| P2860 | cites work | Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 |
| Deregulation of NF-kappaB and its upstream kinases in cancer | Q28190190 | ||
| NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? | Q28235522 | ||
| Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
| Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 | ||
| Blocking of NF-kappaB activation enhances the tumor necrosis factor alpha-induced apoptosis of a human gastric cancer cell line. | Q33186780 | ||
| Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara | Q34343169 | ||
| NF-kappaB as a therapeutic target in cancer | Q34750172 | ||
| Nuclear factor-kappa B and cancer: its role in prevention and therapy | Q34816089 | ||
| NF-kappaB in cancer: a marked target | Q35091120 | ||
| Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth | Q36569036 | ||
| Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells | Q38301767 | ||
| NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells | Q38358712 | ||
| IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy | Q40172372 | ||
| Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer | Q40572213 | ||
| Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines | Q40670865 | ||
| Pyrrolidine dithiocarbamate induces apoptosis by a cytochrome c-dependent mechanism. | Q40899647 | ||
| The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation | Q41280940 | ||
| Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer | Q42437041 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells | Q42524468 | ||
| Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells | Q44059666 | ||
| Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line | Q44563849 | ||
| Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8. | Q44719948 | ||
| Expression of NF-?B in prostate cancer lymph node metastases | Q58325243 | ||
| P433 | issue | 2 | |
| P921 | main subject | NF-κB | Q411114 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 105-110 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | European Surgical Research | Q15755712 |
| P1476 | title | Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines | |
| P478 | volume | 37 |
| Q39127080 | BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells |
| Q36837031 | Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells |
| Q51758254 | Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis. |
| Q39414144 | Effect of antisense oligodeoxynucleotide targeted against NF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer |
| Q38656687 | Expression and function of transforming growth factor‑β‑activated protein kinase 1 in gastric cancer |
| Q35772165 | Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. |
| Q26778007 | Pathophysiological mechanisms of death resistance in colorectal carcinoma |
| Q33567317 | Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway |
| Q42271506 | Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway |
| Q33703901 | Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness |
| Q26850232 | Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone |
| Q39703120 | Upregulation of the GRIM-19 gene suppresses invasion and metastasis of human gastric cancer SGC-7901 cell line |
Search more.